Cumberland Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cumberland Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6% to $39,552,507. Profit margin reached -16%. Total operating expenses were $39,389,886.
Profit Margin
| 2014 | 36.90M | 2.42M | 6.57% |
|---|---|---|---|
| 2015 | 33.51M | 731.35K | 2.18% |
| 2016 | 33.02M | -944.68K | -2.86% |
| 2017 | 41.15M | -7.97M | -19.39% |
| 2018 | 40.74M | -6.96M | -17.09% |
| 2019 | 34.38M | -9.21M | -26.79% |
| 2020 | 37.44M | -6.62M | -17.7% |
| 2021 | 35.98M | -5.59M | -15.55% |
| 2022 | 42.01M | -5.65M | -13.45% |
| 2023 | 39.55M | -6.27M | -15.88% |
CPIX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 39.55M | 42.01M | 35.98M | 37.44M | 34.38M | 40.74M | 41.15M | 33.02M | 33.51M | 36.90M |
Cost of revenue | 6.06M | 9.11M | 8.81M | 8.65M | 7.42M | 7.37M | 7.37M | 5.95M | 4.96M | 5.05M |
Gross profit | 33.48M | 32.89M | 27.17M | 28.78M | 26.96M | 33.36M | 33.77M | 27.06M | 28.55M | 31.84M |
Operating exp. | ||||||||||
Research and development | 5.83M | 6.68M | 5.68M | 5.77M | 6.86M | 7.32M | 3.90M | 3.19M | 3.84M | 3.38M |
Selling and marketing | 18.45M | 16.66M | 15.01M | 14.76M | 15.27M | 20.25M | 21.49M | 14.55M | 13.99M | 14.90M |
Total operating expenses | 39.38M | 38.59M | 34.85M | 35.16M | 36.25M | 40.75M | 37.86M | 28.50M | 27.43M | 28.28M |
Operating income | -6.21M | -5.70M | -7.67M | -6.38M | -9.28M | -7.39M | -4.08M | -1.43M | -1.11M | 3.55M |
Other income (expenses), net | -74.17K | 123.74K | 2.11M | -188.28K | -2.82K | 368.63K | 206.42K | 98.26K | 135.32K | 184.37K |
Income before tax | -6.28M | -5.58M | -5.56M | -6.56M | -9.29M | -7.02M | -3.87M | -1.33M | 1.24M | 3.74M |
Income tax expense | 45.76K | 68.85K | 34.89K | 55.90K | -79.31K | 16.63K | 4.17M | -330.92K | 575.82K | 1.38M |
Net income | -6.27M | -5.65M | -5.59M | -6.62M | -9.21M | -6.96M | -7.97M | -944.68K | 731.35K | 2.42M |
Earnings per share | ||||||||||
Basic EPS | -0.44 | -0.39 | -0.38 | -0.44 | -0.6 | -0.45 | -0.5 | -0.06 | 0.04 | 0.14 |
Diluted EPS | -0.44 | -0.39 | -0.38 | -0.44 | -0.6 | -0.45 | -0.5 | -0.05 | 0.04 | 0.14 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |